IRIDEX Corporation (IRIX) Financial Statements (2026 and earlier)

Company Profile

Business Address 1212 TERRA BELLA AVE
MOUNTAIN VIEW, CA 94043
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments6,0282,3877,03413,92223,85211,626
Cash and cash equivalent6,0282,3877,03413,92223,85211,626
Receivables7,6135,9516,7279,7689,7167,289
Inventory, net of allowances, customer advances and progress billings7,87710,8179,90610,6087,6145,714
Inventory7,87710,8179,90610,6087,6145,714
Other undisclosed current assets3,7344,4073,7831,4681,071730
Total current assets:25,25223,56227,45035,76642,25325,359
Noncurrent Assets
Operating lease, right-of-use asset7681,7922,6321,6652,5651,428
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization58115351462428449
Intangible asset, including goodwill, after accumulated amortization1,9492,2722,6072,9423,170601
Goodwill965965965965965533
Intangible asset, excluding goodwill, after accumulated amortization9841,3071,6421,9772,20568
Other noncurrent assets1,1241,3941,3961,455271132
Total noncurrent assets:3,8995,5736,9866,5246,4342,610
TOTAL ASSETS:29,15129,13534,43642,29048,68727,969
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5,9937,4626,4955,4067,5394,919
Employee-related liabilities✕✕✕✕✕3,1921,965
Accounts payable5,3856,9854,4993,8582,7721,148
Accrued liabilities6084771,9961,5481,5751,806
Deferred revenue2,1602,1762,4042,4112,355938
Debt  3,434   1,249
Other liabilities1,8991,8129259681,098 
Due to related parties✕✕✕✕15627 
Other undisclosed current liabilities3,1561,6753,1503,6531,0271,575
Total current liabilities:13,20816,55912,97412,45312,6468,681
Noncurrent Liabilities
Long-term debt and lease obligation3,7351,004  1,729282
Long-term debt, excluding current maturities3,7351,004    
Liabilities, other than long-term debt7,2869,47511,94012,60611,013392
Accounts payable and accrued liabilities   1381065881
Deferred revenue6,8018,35010,02511,74210,930289
Other liabilities38731426262522
Operating lease, liability988111,7517321,729282
Other undisclosed noncurrent liabilities      1,248
Total noncurrent liabilities:11,02110,47911,94012,60612,7421,922
Total liabilities:24,22927,03824,91425,05925,38810,603
Equity
Equity, attributable to parent, including:4,9222,0979,52217,23123,29917,366
Common stock174174172169168148
Additional paid in capital91,20889,88188,44486,80285,25574,181
Accumulated other comprehensive income (loss)(14)51(52)(24)45(19)
Accumulated deficit(92,446)(88,009)(79,042)(69,716)(62,169)(56,944)
Other undisclosed equity, attributable to parent6,000     
Total equity:4,9222,0979,52217,23123,29917,366
TOTAL LIABILITIES AND EQUITY:29,15129,13534,43642,29048,68727,969

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenues52,67548,66951,86956,97253,90336,347
Cost of revenue(33,448)(29,167)(30,062)(31,604)(31,072)(20,789)
Gross profit:19,22719,50221,80725,36822,83115,558
Operating expenses(21,798)(27,804)(31,814)(32,910)(30,364)(22,141)
Operating loss:(2,571)(8,302)(10,007)(7,542)(7,533)(6,583)
Nonoperating income (expense)(1,809)(540)527602,348280
Interest and debt expense (1,335)(105)    
Loss from continuing operations before equity method investments, income taxes:(5,715)(8,947)(9,480)(7,482)(5,185)(6,303)
Other undisclosed income from continuing operations before income taxes 1,335105    
Loss from continuing operations before income taxes:(4,380)(8,842)(9,480)(7,482)(5,185)(6,303)
Income tax expense(57)(68)(90)(65)(40)(26)
Loss from continuing operations:(4,437)(8,910)(9,570)(7,547)(5,225)(6,329)
Loss before gain (loss) on sale of properties:✕✕✕✕✕(5,225)(6,329)
Net loss available to common stockholders, basic:(4,437)(8,910)(9,570)(7,547)(5,225)(6,329)
Interest on convertible debt 324     
Net loss available to common stockholders, diluted:(4,113)(8,910)(9,570)(7,547)(5,225)(6,329)

Comprehensive Income ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net loss:(4,437)(8,910)(9,570)(7,547)(5,225)(6,329)
Other comprehensive income (loss)(65)46(28)(69)64(99)
Comprehensive loss:(4,502)(8,864)(9,598)(7,616)(5,161)(6,428)
Other undisclosed comprehensive income, net of tax, attributable to parent  57    
Comprehensive loss, net of tax, attributable to parent:(4,502)(8,807)(9,598)(7,616)(5,161)(6,428)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: